Hello! We are a two hospital health system with an outpatient oncology center, so we try to keep our oncology patients in one facility. With all the new indications/uses for biologic treatments (i.e., Rituxan, Remicade), this expectation will be harder to uphold as treatment of Crohn's disease, ILD and certain nephrology conditions should not warrant a transfer. We are starting with our policy to differentiate the credentialing requirements for the administration of chemotherapy and biologic agents used in non-oncology indications.

With the current situation of the COVID-19 pandemic, healthcare workers are faced with considerable stress and anxiety. A concern I have is behavioral drift and deviation from safety practices which would otherwise be normal operating procedure in undistracted workers. At your institutions, is any work being done now to address this potential concern? Am considering messaging with STAR (stop, think, act, review) and am interested in other ideas you may have.
Thanks and be safe!

Hi,
In regards to the current COVID situation, what are various sites doing for ADC precautions and cleaning in your high contact rooms such as trauma, OR, etc. where patient care and the machine are in the same room?

Currently, their is concern that there isn't resource for full decontamination and risk of having to dispose of all contents. Also thoughts of moving machines out of these rooms.

Thanks for the help and support.

if we did dilution of vancomycin in ISO 5 PEC  and put BUD of 48 Hours according to the manufacturer. If I need to withdraw a dose from the above-diluted solution of vancomycin after a while Is it complementary to withdraw a dose in ISO 5 PEC under aseptic condition or can we withdraw a dose from the above vancomycin dilution outside in the normal environment If we withdraw dose outside environment then can we carry on the same Bud of 48 hours for vancomycin 

Is anyone utilizing intravenous lidocaine in the periop setting as part of a multimodal approach to reduce opioid need? Are you willing to share your experience?

If you considered this but are not doing it, why? A Cochrane review published in June 2018 concluded

Hello-

Wondering if anyone has made any changes with compounding solutions for irrigation used in surgery after the removal of bacitracin from the market. We are going to try and use Chlorpactin as an alternative but it is a non-sterile powder and need ideas of how this has been compounded in your site. Thanks in advance!

if there is no information written by the manufacturer for product stability after dilution then what references are you using. Lexicomp provide information about stability of specific brands

HOW MANY DAYS EXPIRY DATE ARE YOU PUTTING AFTER OPENING THE CONTAINER OF EFFERVESCENT TABLET IN YOUR FACILITY

​It's been a while since this question was asked....How does your institution manage medications that cannot be taken by ADULT patients prior to or after sleep study?
Provider order? Which provider?
Assessment of Patient Competence, if self administered in setting of non-clinical staff conducting sleep study?
Patient own medication identification, if not supply by the hospital?

Medication Safety and Informatics Professionals:

Regarding Alert Fatigue, we are looking at modulating the severity to DDI alerts at verification. We have are undergoing an intensive and robust approval process (which can be seen in the attached flowchart). But have come to fears of litigation which really is what got us to this point in the first place (as HER vendors will have everything as a higher level to avoid litigation).